Literature DB >> 11981045

Basal activation of transcription factor signal transducer and activator of transcription (Stat5) in nonpregnant mouse and human breast epithelium.

Marja T Nevalainen1, Jianwu Xie, Lukas Bubendorf, Kay-Uwe Wagner, Hallgeir Rui.   

Abstract

Transcription factor Stat5 (signal transducer and activator of transcription) is essential for PRL-induced terminal differentiation of mouse mammary epithelial cells during pregnancy and lactation and has been implicated in mammary tumorigenesis. A new and sensitive immunological method to detect active, tyrosine phosphorylated Stat5 in situ revealed that Stat5 is continuously activated in luminal epithelial cells of mouse and human breast, not only during pregnancy and lactation, but also outside of pregnancy. Examination of virgin Stat5a or Stat5b null mice suggested that Stat5a was the primary isoform activated in mammary epithelial cells. Basal activation of Stat5 in mammary epithelium of virgin wild-type mice was continuous throughout estrous cycle and was also detected in 17 of 17 normal human breast tissue specimens analyzed. PRL was identified as the principal factor maintaining basal activation of Stat5 in mammary epithelium of nonpregnant mice based on several lines of evidence. First, administration of PRL, but not GH or epidermal growth factor, uniformly enhanced basal activation of Stat5 in luminal mammary epithelial cells. Second, hypophysectomy disrupted basal activation of Stat5, an effect that was completely reversed by administration of PRL, but only partially by GH. Third, knock-out of the PRL receptor gene markedly reduced basal activation of Stat5, an effect that was maintained in a normalized endocrine environment after transplanting PRL receptor null mammary epithelium into wild-type mice. Continuous activation of Stat5 indicates a role of this transcription factor in normal, nonpregnant breast epithelial cells, and may shed new light on Stat5 involvement in breast tumor promotion.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11981045     DOI: 10.1210/mend.16.5.0839

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  37 in total

Review 1.  Phosphorylation state-specific antibodies: applications in investigative and diagnostic pathology.

Authors:  James W Mandell
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

Review 2.  Roles and regulation of stat family transcription factors in human breast cancer.

Authors:  Charles V Clevenger
Journal:  Am J Pathol       Date:  2004-11       Impact factor: 4.307

3.  Positive STAT5 Protein and Locus Amplification Status Predicts Recurrence after Radical Prostatectomy to Assist Clinical Precision Management of Prostate Cancer.

Authors:  Bassem R Haddad; Andrew Erickson; Vindhya Udhane; Peter S LaViolette; Janice D Rone; Markku A Kallajoki; William A See; Antti Rannikko; Tuomas Mirtti; Marja T Nevalainen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-07-10       Impact factor: 4.254

4.  Loss of nuclear localized and tyrosine phosphorylated Stat5 in breast cancer predicts poor clinical outcome and increased risk of antiestrogen therapy failure.

Authors:  Amy R Peck; Agnieszka K Witkiewicz; Chengbao Liu; Ginger A Stringer; Alexander C Klimowicz; Edward Pequignot; Boris Freydin; Thai H Tran; Ning Yang; Anne L Rosenberg; Jeffrey A Hooke; Albert J Kovatich; Marja T Nevalainen; Craig D Shriver; Terry Hyslop; Guido Sauter; David L Rimm; Anthony M Magliocco; Hallgeir Rui
Journal:  J Clin Oncol       Date:  2011-05-16       Impact factor: 44.544

Review 5.  Hormone-sensing mammary epithelial progenitors: emerging identity and hormonal regulation.

Authors:  Gerard A Tarulli; Geraldine Laven-Law; Reshma Shakya; Wayne D Tilley; Theresa E Hickey
Journal:  J Mammary Gland Biol Neoplasia       Date:  2015-09-21       Impact factor: 2.673

6.  STAT 5a expression in various lesions of the breast.

Authors:  Gary L Bratthauer; Brian L Strauss; Fattaneh A Tavassoli
Journal:  Virchows Arch       Date:  2005-08-19       Impact factor: 4.064

7.  Signal transducer and activator of transcription 5a mediates mammary ductal branching and proliferation in the nulliparous mouse.

Authors:  Sarah J Santos; Sandra Z Haslam; Susan E Conrad
Journal:  Endocrinology       Date:  2010-04-14       Impact factor: 4.736

8.  Aberrantly high expression of the CUB and zona pellucida-like domain-containing protein 1 (CUZD1) in mammary epithelium leads to breast tumorigenesis.

Authors:  Janelle Mapes; Lavanya Anandan; Quanxi Li; Alison Neff; Charles V Clevenger; Indrani C Bagchi; Milan K Bagchi
Journal:  J Biol Chem       Date:  2018-01-10       Impact factor: 5.157

9.  Role of ERalpha in the differential response of Stat5a loss in susceptibility to mammary preneoplasia and DMBA-induced carcinogenesis.

Authors:  Anne M Miermont; Angela R Parrish; Priscilla A Furth
Journal:  Carcinogenesis       Date:  2010-02-24       Impact factor: 4.944

10.  Ovarian hormones are not required for PRL-induced mammary tumorigenesis, but estrogen enhances neoplastic processes.

Authors:  Lisa M Arendt; Lindsay C Evans; Debra E Rugowski; Maria Jose Garcia-Barchino; Hallgeir Rui; Linda A Schuler
Journal:  J Endocrinol       Date:  2009-07-27       Impact factor: 4.286

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.